C-
Overall grade
C
Financial quality
The sleeper story everyone's missing: Oscar's ICHRA pivot isn't diversification theater-they just acquired one of only 11 CMS-approved direct enrollment platforms while the ACA market implodes around them. The obvious headline is the 1,200 basis point MLR blowout and swing to losses, but that's market-wide morbidity (mid-to-high single digit increases per Wakeley data) that they're aggressively repricing with 'significant double-digit' rate hikes. The binding constraint is capital adequacy-they burned $328M excess capital in one quarter and parent cash declines in the back half while they scramble to extend their revolver. Management's most revealing quote: regulators asking 'are we all priced properly, they don't want their markets to fail.' My view changes if their 2026 rate filings get rejected or if the ICHRA pipeline shows actual traction with measurable employer commitments.
The 30-second version
- The sleeper story: ICHRA pivot becoming their 2026 safety net
- Market morbidity crisis is real but Oscar's repricing aggressively
- The metric that disappeared: No more excess capital guidance
What changed this quarter
| Metric | Prior | This quarter |
|---|---|---|
| Revenue | $3.0B (42% YoY) | $2.9B (29% YoY) |
| MLR | 75.4% (+120 bps YoY) | 91.1% (+1200 bps YoY) |
| Operating Loss | $297M profit | $230M loss |
| Net Loss | $275M profit | $228M loss |
| SG&A Ratio | 15.8% (-260 bps YoY) | 18.7% (-90 bps YoY) |
| Membership | 2.0M (41% YoY) | 2.0M+ (28% YoY) |
| Excess Capital | $907M | $579M |
| Risk Adjustment Payable | $92M unfavorable 2024 true-up | $316M incremental for 2025 |
Accountability tracked
7 new promises made4 narrative shifts flagged6 prior promises graded
Inside the full report
The complete write-up covers the full promise ledger with kept/missed calls, disclosure-quality scoring, the metrics-vanished check, verification items, and the questions to ask next quarter.
Subscribe to Call Sheet Daily →